vancomycin has been researched along with quercetin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Hossion, AM; Iwado, A; Kandahary, RK; Ogawa, W; Otsuka, N; Sasaki, K; Tsuchiya, T; Zamami, Y | 1 |
| Hossion, AM; Iwado, A; Kandahary, RK; Ogawa, W; Sasaki, K; Tsuchiya, T; Zamami, Y | 1 |
| Hossion, AM; Sasaki, K | 1 |
1 review(s) available for vancomycin and quercetin
| Article | Year |
|---|---|
Novel quercetin glycosides as potent anti-MRSA and anti-VRE agents.
Topics: Anti-Bacterial Agents; Glycosides; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Patents as Topic; Quercetin; Staphylococcal Infections; Vancomycin; Vancomycin-Resistant Enterococci | 2013 |
3 other study(ies) available for vancomycin and quercetin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Design, synthesis, and biological evaluation of a novel series of quercetin diacylglucosides as potent anti-MRSA and anti-VRE agents.
Topics: Anti-Bacterial Agents; Drug Design; Enterococcus; Glucosides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Quercetin; Vancomycin | 2010 |
Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents.
Topics: Animals; Anti-Bacterial Agents; DNA Topoisomerase IV; Drug Design; Enzyme Inhibitors; Galactosides; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Targeted Therapy; Quercetin; Rats; Rats, Wistar; Topoisomerase II Inhibitors | 2011 |